Dr. Jonathan A. Bernstein, MD

Dr. Bernstein practices at Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare.

Dr. Bernstein's NPI, 1093713638, was assigned on July 8, 2005. Dr. Bernstein graduated from University Of Cincinnati College Of Medicine in 1985. Dr. Bernstein holds Ohio license 35 053762.

Dr. Bernstein's primary practice is Kettering Health Dayton, at 405 Grand Avenue, Dayton, OH 45405 in Montgomery County. The practice phone is (937) 723-3410.

Dr. Bernstein's primary practice is Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare. Dmand AI also links Dr. Bernstein to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernstein practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Bernstein's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Bernstein is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Bernstein's licenses on file in 4 states: Ohio, Kentucky, Indiana and Illinois.

Dmand AI lists asthma, chronic nasal allergies, chronic sinusitis, hives and immune deficiency disease among the conditions Dr. Bernstein treats.

CMS data shows 918 Medicare services from Dr. Bernstein across 9 procedure codes in 2024, for 276 Medicare patients. Medicare paid $43,495 for them. Every service was in an office.

CMS counts 276 Medicare patients who saw Dr. Bernstein in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bernstein's median patient age at 46, with 65% women.

In 2024, Dr. Bernstein wrote 2,505 Medicare Part D claims for 334 patients. 68% of them were for generic drugs. CMS names the drug for 2,221 of them, across 53 drugs with 11 or more claims each, at $3,165,398 in total drug cost. In 2023, CMS named 2,157 claims across 50 drugs.

Dmand AI links 335 papers to Dr. Bernstein, published from 2007 to 2025. 2023 was the busiest year, with 34. The most frequent topics are Angioedemas, Hereditary, Complement C1 Inhibitor Protein and Asthma. Dr. Bernstein has published most often in J Allergy Clin Immunol Pract. Dr. Bernstein's most frequent co-authors are Jonathan Bernstein, MD, Marc Andrew Riedl, MD and Timothy J. Craig, DO.

Dmand AI links Dr. Bernstein to 12 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Hereditary Complement Deficiency Diseases, Angioedemas, Hereditary and Asthma. Shire sponsors the most, 4. Open Payments lists research payments to Dr. Bernstein that name 5 trials.

CMS Open Payments shows 1,717 general payments to Dr. Bernstein from 55 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 41% of the total. Shire North American Group Inc paid the most, $235,841. It also lists 72 research payments totaling $108,287 from 2016 to 2025, naming 5 clinical trials.

Dmand AI lists 8 awards for Dr. Bernstein, most recently Top Doctor in 2022.

Dr. Bernstein graduated from University Of Cincinnati College Of Medicine in 1985. Dr. Bernstein is a member of AAAAI.

Dr. Bernstein is in network with 16 carriers, including Excellus BlueCross BlueShield, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.